Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke

Ruhr University of Bochum400 enrolled

Overview

The aim of this study is to evaluate the low-response prevalence of early antiplatelet therapy and to test the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).

Antiplatelet agents are important therapeutic options in treating patients with acute ischemic strokes to prevent recurrent ischemic events or death. The aim of this study was to evaluate the low-response prevalence of early antiplatelet therapy and the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Test the Efficacy of Antiplatelet Regimes in Acute Stroke

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * suspected acute cerebrovascular ischemic events and patients who were admitted to the stroke unit where antiplatelet therapy was initiated Exclusion Criteria: * severe liver disorders, current gastrointestinal disorders, congestive heart failure, life-threatening malignancies and a personal or family history of bleeding disorders

Locations (1)

Department of Neurology, St. Josef - Hospital, Ruhr-University

Bochum, North Rhine-Westphalia, Germany

Outcomes

Primary Outcomes

Result of platelet function test

Aggregometry result of antiplatelet therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.